24,502 Shares in Baxter International Inc. $BAX Bought by One Way Holdings LLC

One Way Holdings LLC bought a new position in shares of Baxter International Inc. (NYSE:BAX) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 24,502 shares of the medical instruments supplier’s stock, valued at approximately $588,000.

Several other institutional investors and hedge funds have also bought and sold shares of BAX. BlackRock Inc. purchased a new position in shares of Baxter International during the 2nd quarter valued at $1,744,874,000. Pzena Investment Management LLC bought a new position in shares of Baxter International in the second quarter worth $1,392,098,000. Equity Investment Corp bought a new position in shares of Baxter International in the second quarter worth $146,815,000. Bank of America Corp DE purchased a new stake in shares of Baxter International in the second quarter worth $132,993,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Baxter International in the second quarter worth $68,036,000. 90.19% of the stock is currently owned by hedge funds and other institutional investors.

Baxter International Price Performance

Shares of NYSE:BAX opened at $24.15 on Tuesday. The company’s fifty day moving average price is $24.54 and its 200-day moving average price is $21.39. The firm has a market capitalization of $12.49 billion, a price-to-earnings ratio of -17.13, a PEG ratio of 3.85 and a beta of 0.65. Baxter International Inc. has a one year low of $15.73 and a one year high of $30.00. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.95 and a quick ratio of 1.32.

Baxter International (NYSE:BAX) last posted its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. The company had revenue of $2.98 billion during the quarter, compared to the consensus estimate of $2.91 billion. During the same period in the previous year, the firm posted $0.69 EPS. The firm’s revenue was up 5.0% compared to the same quarter last year. On average, equities research analysts anticipate that Baxter International Inc. will post 2.10 earnings per share for the current fiscal year.

Baxter International Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, November 27th will be given a dividend of $0.01 per share. The ex-dividend date is Friday, November 27th. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. Baxter International’s dividend payout ratio (DPR) is presently -2.84%.

Wall Street Analysts Forecast Growth

BAX has been the subject of several research analyst reports. Jefferies Financial Group reissued a “hold” rating and set a $25.00 price objective on shares of Baxter International in a research note on Thursday. Wall Street Zen upgraded Baxter International from a “hold” rating to a “buy” rating in a research note on Saturday. JPMorgan Chase & Co. lowered their price target on Baxter International from $26.00 to $25.00 and set a “neutral” rating on the stock in a report on Friday. UBS Group raised their price target on Baxter International from $19.00 to $25.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. Finally, Zacks Research upgraded Baxter International from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. One equities research analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus price target of $23.00.

About Baxter International

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.